1Pitt B, Zannad F, Remme W J, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators [J]. N Eng J Med,1999,341 (10):709-717.
2Zannad F, McMurray J J, Krum H, et al. Eplerenone in patients with systolic heart failure and mild symptoms [J]. N Eng J Med, 2011,364(1):11-21.
3Swedberg K, Komajda M, Bohm M, et al. Ivabradine and out- comes in chronic heart failure (SHIFT) : a randomized placebo- controlled study[J]. Lancet,2010,376(9744): 875-885.
4Smith C R, Leon M B, Mack M J, et al. Transcatheter versus surgical aortic-valve replacement in high risk patients [J]. N Eng J Med,2011,364(23) :2187-2198.
5Camm A J, Kirchhof P, Lip G Y, et al. Guidelines for the manage- ment of atrial fibrillation: The Task Force for the Management of Atrial Fibriallation of the European Society of Cardiology(ESC) [J]. Europace, 2010,12(10) : 1360- 1420.
6Krurn H, Jelinek M V, Stewart S, et al. 2011 update to National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Guidelines for the prevention, detection and manage- ment of chronic heart failure in Australia, 2006 [J]. Med J Aust, 2011,194(8) :405-409.
7McMllrray J J,Swedberg K. HEAAL:the final chapter in the story of angiotensin receptor blocker in heart failure-lessons learnt from adecade of trials[J]. EurJ Henrt Fail,2010,12(2):99-103.
8Chow SL,O'Barr SA,Peng J,et al.Renal function and neurohormonal changes follow ing intravenous infusions of nitroglycerin versus nesiritide in patients w ith acute decompensated heart failure[J].J Card Fail,2011,17(3):181-187.
9Chow SL,Peng JT,Okamoto MP,et al.Effect of nesiritide infusion duration on renal function in acutely decompensated heart falure patients[J].Ann P Harmacother,2007,41(4):556-561.
10Witteles RM.Nesiritide,heartfailure,and renal dysfunction:irrational exuberance or throw ing the baby out w ith the bathw ater[J].Cardiovase Drugs Ther,2009,23(2):183-186.
